CTAC NV (CTAC.AS) Fundamental Analysis & Valuation

AMS:CTAC • NL0000345577

Current stock price

2.84 EUR
+0.09 (+3.27%)
Last:

This CTAC.AS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. CTAC.AS Profitability Analysis

1.1 Basic Checks

  • In the past year CTAC was profitable.
  • In the past year CTAC had a positive cash flow from operations.
  • In the past 5 years CTAC has always been profitable.
  • CTAC had a positive operating cash flow in each of the past 5 years.
CTAC.AS Yearly Net Income VS EBIT VS OCF VS FCFCTAC.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M 10M 15M

1.2 Ratios

  • The Return On Assets of CTAC (7.74%) is better than 82.19% of its industry peers.
  • CTAC has a better Return On Equity (16.41%) than 73.97% of its industry peers.
  • CTAC has a Return On Invested Capital of 9.71%. This is in the better half of the industry: CTAC outperforms 60.27% of its industry peers.
  • CTAC had an Average Return On Invested Capital over the past 3 years of 10.26%. This is below the industry average of 12.44%.
Industry RankSector Rank
ROA 7.74%
ROE 16.41%
ROIC 9.71%
ROA(3y)3.98%
ROA(5y)4.84%
ROE(3y)8.98%
ROE(5y)11.99%
ROIC(3y)10.26%
ROIC(5y)11.02%
CTAC.AS Yearly ROA, ROE, ROICCTAC.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • CTAC has a Profit Margin (2.86%) which is in line with its industry peers.
  • CTAC's Profit Margin has declined in the last couple of years.
  • CTAC has a Operating Margin of 2.63%. This is in the lower half of the industry: CTAC underperforms 72.60% of its industry peers.
  • In the last couple of years the Operating Margin of CTAC has declined.
  • CTAC has a worse Gross Margin (35.24%) than 67.12% of its industry peers.
  • CTAC's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.63%
PM (TTM) 2.86%
GM 35.24%
OM growth 3Y-12.38%
OM growth 5Y-6.66%
PM growth 3Y-10.68%
PM growth 5Y-3.79%
GM growth 3Y-5.01%
GM growth 5Y-4.72%
CTAC.AS Yearly Profit, Operating, Gross MarginsCTAC.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. CTAC.AS Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CTAC is creating some value.
  • The number of shares outstanding for CTAC remains at a similar level compared to 1 year ago.
  • CTAC has more shares outstanding than it did 5 years ago.
  • CTAC has a better debt/assets ratio than last year.
CTAC.AS Yearly Shares OutstandingCTAC.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M
CTAC.AS Yearly Total Debt VS Total AssetsCTAC.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • CTAC has an Altman-Z score of 4.01. This indicates that CTAC is financially healthy and has little risk of bankruptcy at the moment.
  • CTAC has a Altman-Z score of 4.01. This is amongst the best in the industry. CTAC outperforms 84.93% of its industry peers.
  • CTAC has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of CTAC (0.16) is better than 76.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z 4.01
ROIC/WACC1.44
WACC6.73%
CTAC.AS Yearly LT Debt VS Equity VS FCFCTAC.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M

2.3 Liquidity

  • CTAC has a Current Ratio of 1.10. This is a normal value and indicates that CTAC is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.10, CTAC is doing worse than 61.64% of the companies in the same industry.
  • CTAC has a Quick Ratio of 1.10. This is a normal value and indicates that CTAC is financially healthy and should not expect problems in meeting its short term obligations.
  • CTAC has a Quick ratio (1.10) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 1.1
CTAC.AS Yearly Current Assets VS Current LiabilitesCTAC.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. CTAC.AS Growth Analysis

3.1 Past

  • The earnings per share for CTAC have decreased by -7.93% in the last year.
  • CTAC shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.95% yearly.
  • CTAC shows a small growth in Revenue. In the last year, the Revenue has grown by 1.11%.
  • Measured over the past years, CTAC shows a small growth in Revenue. The Revenue has been growing by 7.56% on average per year.
EPS 1Y (TTM)-7.93%
EPS 3Y-9.43%
EPS 5Y2.95%
EPS Q2Q%-18.74%
Revenue 1Y (TTM)1.11%
Revenue growth 3Y2.23%
Revenue growth 5Y7.56%
Sales Q2Q%0.78%

3.2 Future

  • The Earnings Per Share is expected to decrease by 0.00% on average over the next years.
  • Based on estimates for the next years, CTAC will show a small growth in Revenue. The Revenue will grow by 7.04% on average per year.
EPS Next Y16.07%
EPS Next 2Y7.74%
EPS Next 3Y0%
EPS Next 5YN/A
Revenue Next Year4.33%
Revenue Next 2Y4.24%
Revenue Next 3Y2.31%
Revenue Next 5Y7.04%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CTAC.AS Yearly Revenue VS EstimatesCTAC.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M
CTAC.AS Yearly EPS VS EstimatesCTAC.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.1 0.2 0.3

More info and screens

Find the best growth stocksShow best growing peers

6

4. CTAC.AS Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 11.36, the valuation of CTAC can be described as very reasonable.
  • Based on the Price/Earnings ratio, CTAC is valued cheaper than 84.93% of the companies in the same industry.
  • CTAC is valuated cheaply when we compare the Price/Earnings ratio to 26.91, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 8.57, the valuation of CTAC can be described as very reasonable.
  • Based on the Price/Forward Earnings ratio, CTAC is valued a bit cheaper than 78.08% of the companies in the same industry.
  • CTAC is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.69, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.36
Fwd PE 8.57
CTAC.AS Price Earnings VS Forward Price EarningsCTAC.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • CTAC's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CTAC is cheaper than 86.30% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.22
CTAC.AS Per share dataCTAC.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • CTAC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.71
PEG (5Y)3.85
EPS Next 2Y7.74%
EPS Next 3Y0%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. CTAC.AS Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 4.14%, CTAC is a good candidate for dividend investing.
  • CTAC's Dividend Yield is a higher than the industry average which is at 2.76.
  • CTAC's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 4.14%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2
CTAC.AS Yearly Dividends per shareCTAC.AS Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.02 0.04 0.06 0.08 0.1

5.3 Sustainability

  • 28.82% of the earnings are spent on dividend by CTAC. This is a low number and sustainable payout ratio.
DP28.82%
EPS Next 2Y7.74%
EPS Next 3Y0%
CTAC.AS Yearly Income VS Free CF VS DividendCTAC.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M 10M
CTAC.AS Dividend Payout.CTAC.AS Dividend Payout, showing the Payout Ratio.CTAC.AS Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CTAC.AS Fundamentals: All Metrics, Ratios and Statistics

CTAC NV

AMS:CTAC (4/8/2026, 7:00:00 PM)

2.84

+0.09 (+3.27%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners5.23%
Inst Owner ChangeN/A
Ins Owners22.27%
Ins Owner ChangeN/A
Market Cap40.19M
Revenue(TTM)188.71M
Net Income(TTM)5.40M
Analysts80
Price Target2.87 (1.06%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.14%
Yearly Dividend0.11
Dividend Growth(5Y)N/A
DP28.82%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-3.44%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-22.62%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.36%
Valuation
Industry RankSector Rank
PE 11.36
Fwd PE 8.57
P/S 0.21
P/FCF N/A
P/OCF 63.89
P/B 1.22
P/tB 5.63
EV/EBITDA 4.22
EPS(TTM)0.25
EY8.8%
EPS(NY)0.33
Fwd EY11.67%
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)0.04
OCFY1.57%
SpS13.34
BVpS2.33
TBVpS0.5
PEG (NY)0.71
PEG (5Y)3.85
Graham Number3.62
Profitability
Industry RankSector Rank
ROA 7.74%
ROE 16.41%
ROCE 12.62%
ROIC 9.71%
ROICexc 11%
ROICexgc 42.74%
OM 2.63%
PM (TTM) 2.86%
GM 35.24%
FCFM N/A
ROA(3y)3.98%
ROA(5y)4.84%
ROE(3y)8.98%
ROE(5y)11.99%
ROIC(3y)10.26%
ROIC(5y)11.02%
ROICexc(3y)12.83%
ROICexc(5y)13.89%
ROICexgc(3y)121.73%
ROICexgc(5y)145.43%
ROCE(3y)13.49%
ROCE(5y)14.56%
ROICexgc growth 3Y-18.29%
ROICexgc growth 5Y-22.64%
ROICexc growth 3Y-9.77%
ROICexc growth 5Y-4.88%
OM growth 3Y-12.38%
OM growth 5Y-6.66%
PM growth 3Y-10.68%
PM growth 5Y-3.79%
GM growth 3Y-5.01%
GM growth 5Y-4.72%
F-Score6
Asset Turnover2.71
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA 0.52
Cap/Depr 28.44%
Cap/Sales 0.81%
Interest Coverage 13.63
Cash Conversion 6.08%
Profit Quality N/A
Current Ratio 1.1
Quick Ratio 1.1
Altman-Z 4.01
F-Score6
WACC6.73%
ROIC/WACC1.44
Cap/Depr(3y)42.32%
Cap/Depr(5y)33.13%
Cap/Sales(3y)1.77%
Cap/Sales(5y)1.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7.93%
EPS 3Y-9.43%
EPS 5Y2.95%
EPS Q2Q%-18.74%
EPS Next Y16.07%
EPS Next 2Y7.74%
EPS Next 3Y0%
EPS Next 5YN/A
Revenue 1Y (TTM)1.11%
Revenue growth 3Y2.23%
Revenue growth 5Y7.56%
Sales Q2Q%0.78%
Revenue Next Year4.33%
Revenue Next 2Y4.24%
Revenue Next 3Y2.31%
Revenue Next 5Y7.04%
EBIT growth 1Y-10.74%
EBIT growth 3Y-10.42%
EBIT growth 5Y0.4%
EBIT Next Year118.18%
EBIT Next 3Y29.7%
EBIT Next 5YN/A
FCF growth 1Y-112.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-93.88%
OCF growth 3Y-52.08%
OCF growth 5Y-47.08%

CTAC NV / CTAC.AS Fundamental Analysis FAQ

What is the fundamental rating for CTAC stock?

ChartMill assigns a fundamental rating of 5 / 10 to CTAC.AS.


Can you provide the valuation status for CTAC NV?

ChartMill assigns a valuation rating of 6 / 10 to CTAC NV (CTAC.AS). This can be considered as Fairly Valued.


What is the profitability of CTAC stock?

CTAC NV (CTAC.AS) has a profitability rating of 4 / 10.


How financially healthy is CTAC NV?

The financial health rating of CTAC NV (CTAC.AS) is 5 / 10.


Can you provide the expected EPS growth for CTAC stock?

The Earnings per Share (EPS) of CTAC NV (CTAC.AS) is expected to grow by 16.07% in the next year.